PMID: 9161659May 1, 1997Paper

Pegaspargase: an alternative?

The Annals of Pharmacotherapy
L M Holle

Abstract

To review the chemistry, pharmacology, pharmacokinetics, clinical activity, adverse effects, dosage, and administration guidelines for pegaspargase. A MEDLINE search (1980-1996), a CANCERLIT search (1983-1996), and a CURRENT CONTENTS search (1980-1996) using the terms pegaspargase, PEG-asparaginase, PEG-L-asparaginase, polyethylene glycol L-asparaginase, polyethylene glycol conjugated L-asparaginase, and Oncaspar were conducted. All articles were considered for possible inclusion in this review. Abstracts were included only when they were judged to add critical information not otherwise available in the medical literature. L-Asparaginase has been a main component of treatment regimens for acute lymphocytic leukemia. A key limiting factor of L-asparaginase use has been the development of hypersensitivity to the drug. Recently, a polyethylene glycol (PEG) conjugated form of L-asparaginase, pegaspargase, has been made available. PEG modification of L-asparaginase has been shown to alter the tendency of the enzyme to induce an immune response and to extend the half-life of the drug. The majority of patients with hypersensitivity to the native enzyme preparations tolerate pegaspargase without further clinical hypersensitivity. The a...Continue Reading

References

May 1, 1992·Allergy Proceedings : the Official Journal of Regional and State Allergy Societies·P L KwittkenS Sweinberg
Jan 1, 1990·Annals of the New York Academy of Sciences·H WadaY Inada
Feb 1, 1990·Investigational New Drugs·H B MussD R White
Jan 1, 1970·Annual Review of Medicine·R L CapizziR E Handschumacher
Aug 1, 1980·Proceedings of the National Academy of Sciences of the United States of America·T TamuraY Hirota
Oct 1, 1994·Clinical Pharmacokinetics·R Duncan, F Spreafico
Jan 19, 1994·Journal of the National Cancer Institute·S L BergJ A O'Shaughnessy
Sep 1, 1993·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·B L AsselinH J Cohen
Jan 1, 1993·Leukemia & Lymphoma·R L Capizzi

❮ Previous
Next ❯

Citations

Aug 25, 2001·BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy·A KozlowskiJ M Harris
Dec 23, 2003·Expert Review of Anticancer Therapy·Toni K ChoueiriRonald M Bukowski
Nov 1, 2008·Expert Opinion on Drug Discovery·Mehrdad HamidiAmir Azadi
May 15, 2013·Leukemia & Lymphoma·Kuldeep KumarDiwakar Aggarwal
Dec 4, 2003·Expert Opinion on Biological Therapy·Gerd Kochendoerfer
Apr 3, 2004·British Journal of Haematology·João Paulo Vieira Pinheiro, Joachim Boos
Mar 17, 2007·Critical Reviews in Biotechnology·Neelam VermaSneh Anand
Apr 14, 2015·Critical Reviews in Microbiology·Prajna Rao KrishnapuraSandeep Subramanya
Aug 21, 2001·Clinical Pharmacokinetics·J M HarrisM Modi
Nov 11, 2006·International Journal of Cancer. Journal International Du Cancer·Cheol-Yong YoonBon-Hong Min
Sep 24, 2004·International Journal of Cancer. Journal International Du Cancer·Eun-Joo NohBon-Hong Min
Feb 1, 2010·Viruses·Piyanuch Wonganan, Maria A Croyle
Oct 12, 2007·Drugs·Effrosyni ApostolidouFrancis J Giles
May 18, 2011·Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics·Carolyn K PanJeffrey L Olson
Jan 5, 2002·Cancer Chemotherapy and Pharmacology·J P Vieira PinheiroJ Boos
Dec 10, 2008·Expert Opinion on Biological Therapy·Amer ZeidanMeir Wetzler
Dec 22, 2007·Nature Reviews. Drug Discovery·Benjamin LeaderDavid E Golan
Sep 28, 2006·Drug Delivery·Mehrdad HamidiPedram Rafiei
Mar 4, 2003·Nature Reviews. Drug Discovery·J Milton Harris, Robert B Chess
Apr 4, 2009·Anti-cancer Drugs·Ekaterini SyrigouKostas N Syrigos
Mar 8, 2003·Drug Discovery Today·Vladimir P Torchilin, Anatoly N Lukyanov
May 4, 2005·Journal of Controlled Release : Official Journal of the Controlled Release Society·Giangthy N TonGlen S Kwon
Aug 30, 2008·International Journal of Pharmaceutics·Rui WangSheng Zhang

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allergy and Asthma

Allergy and asthma are inflammatory disorders that are triggered by the activation of an allergen-specific regulatory t cell. These t cells become activated when allergens are recognized by allergen-presenting cells. Here is the latest research on allergy and asthma.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.